Influence of amphotericin B and amphotericin B colloidal dispersion on the functions of human phagocytes in defence against Aspergillus species

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 26, Issue 6, 2007, Pages 413-417

  Perkhofer, S ^a   Blum, G ^a   Speth, C ^a   Mayr, A ^a   Dierich, M P ^a   Lass Florl C ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE;

ARTICLE; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; CELLULAR IMMUNITY; CONIDIUM; CONTROLLED STUDY; FUNGAL SPORE GERMINATION; FUNGUS ISOLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MONOCYTE; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS; CELLS, CULTURED; HUMANS; PHAGOCYTES; PHAGOCYTOSIS; SPORES, FUNGAL;

EID: 34249905196     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-007-0300-x     Document Type: Article

References (25)

1. Denning DW (1991) Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host. J Antimicrob Chemother 28(Suppl B):1-16
2. Gerson LS, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA (1984) Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 100:345-351
3. Richardson MD (1998) Antifungal therapy in bone marrow failure. Brit J Haematol 100:619-628
4. Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens D (1991) Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 324:654-662
5. Offner F, Cordonnier C, Ljungman P, Prentice HG, Engelhard D, De Bacquer D, Meunier F, De Pauw B (1998) Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis 26:1098-1103
6. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408-415
7. Lass-Florl C, Griff K, Mayr A, Petzer A, Gastl G, Bonatti H, Freund M, Kropshofer G, Dierich MP, Nachbaur D (2005) Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol 131:201-207
8. Graybill JR, Hernandez S, Bocanegra R, Najvar LK (2004) Antifungal therapy of murine Aspergillus terreus infection. Antimicrob Agents Chemother 48:3715-3719
9. Walsh TJ, Pizzo P. (1988) Nosocomial fungal infections: a classification for hospital-acquired fungal infections and mycoses arising from endogenous flora or reactivation. Ann Rev Microbiol 42:517-545
10. Marr KA, Boeckh M, Carter RA, Kim HW, Corey L (2004) Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis 39:797-802
11. Roilides E, Sein T, Holmes A, Chanock S, Blake C, Pizzo PA, Walsh TJ (1995) Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Infect Dis 172:1028-1034
12. Schaffner A, Douglas H, Braude A (1982) Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defence in vivo and in vitro with human and mouse phagocytes. J Clin Invest 69:617-631
13. Schaffner A, Douglas H, Braude A, Davis C (1983) Killing of Aspergillus spores depends on the anatomical source of the macrophage. Infect Immun 42:1109-1115
14. Groll A, Walsh JT (2002) Antifungal chemotherapy: advances and perspectives. Swiss Med Wkly 132:303-311
15. Bauters T, Buyle F, Peleman R, Robays H (2005) Antifungal drugs and rational use of antifungals in treating invasive aspergillosis: the role of the hospital pharmacist. Pharm World Sci 27:31-34
16. Glasmacher A, Cornely O, Ullmann AJ, Wedding U, Bodenstein H, Wandt H, Boewer C, Pasold R, Wolf HH, Hänel M, Dölken G, Junghanss C, Andreesen R, Bertz H (2006) An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. J Antimicrob Chemother 57:317-325
17. Walsh TJ, Teppler H, Donowitz Gr, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE (2004) Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 347:1391-1402
18. Espinel-Ingroff A, Dawson K, Pfaller M, Anaissie E, Breslin B, Dixon D, Fothergill A, Paetznick V, Peter J, Rinaldi M, Walsh TJ (1995) Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrob Agents Chemother 39:314-319
19. Kacani L, Frank I, Spruth M, Schwendinger MG, Mullauer B, Sprinzl GM, Steindl F, Dierich MP (1998) Dentritic cells transmit human immunodeficiency virus type 1 to monocytes and monocyte-derived macrophages. J Virol 72:6671-6677
20. Murayama T, Amitani R, Ikegami Y, Newada R, Lee WJ, Kuze F (1996) Suppressive effects of Aspergillus fumigatus culture filtrates on human alveolar macrophages and polymorphonuclear leucocytes. Eur Respir J 9:293-300
21. Murayama T, Amitani R, Ikegami Y, Kawanami R, Lee WJ, Nawada R (1998) Effects of Aspergillus fumigatus culture filtrate on antifungal activity of human phagocytes in vitro. Thorax 53:975-978
22. Waldorf AR, Levitz SM, Diamond RD (1984) In vivo bronchoalveolar macrophage defence against Rhizopus oryzae and Aspergillus fumigatus. J Infect Dis 150:752-760
23. Pallister CJ, Johnson EM, Warnock DW, Elliot PJ, Reed DF (1992) In-vitro effects of liposome-encapsulated amphotericin B (AmBisome) and amphotericin B-deoxycholate (Fungizone) on the phagocytic and candidacidal function of human polymorphonuclear leucocytes. J Antimicrob Chemother 30:313-320
24. Van der Auwera P (1990) In vitro tests of the functions of phagocytic cells and their interaction with antimicrobial agents: a critical review. J Antimicrob Agents 26:169-173
25. Roilides E, Uhlig K, Venzon D, Pizzo P, Walsh TJ (1993) Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 61:1185-1193